Cellectis (CLLS) Gross Profit Growth (3y) (2018 - 2023)
Cellectis (CLLS) Gross Profit Growth (3y) (2018 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 54.36% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.16% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 3.86% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 79.18% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Cellectis | 285.50 Mn | 99.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 28.57% |
| Sep 30, 2023 | 49.45% |
| Jun 30, 2023 | 26.87% |
| Mar 31, 2023 | -26.08% |
| Dec 31, 2022 | 26.71% |
| Sep 30, 2022 | -26.94% |
| Jun 30, 2022 | 42.64% |
| Mar 31, 2022 | -58.57% |
| Dec 31, 2021 | -30.96% |
| Sep 30, 2021 | -195.15% |
| Jun 30, 2021 | -27.53% |
| Mar 31, 2021 | -34.42% |
| Dec 31, 2020 | -41.43% |
| Sep 30, 2020 | -31.91% |
| Jun 30, 2020 | -32.92% |
| Mar 31, 2020 | 67.53% |
| Dec 31, 2019 | -27.34% |
| Sep 30, 2019 | -27.09% |
| Jun 30, 2019 | -74.43% |
| Mar 31, 2019 | -60.35% |